Matches in Nanopublications for { ?s ?p "[The strongest c-erbB-2 immunoexpression was observed in low grade astrocytomas (diffuse astrocytomas G2); in the glioblastoma group the c-erbB-2 protein expression was weak and 17.4% of cases were negative.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[The strongest c-erbB-2 immunoexpression was observed in low grade astrocytomas (diffuse astrocytomas G2); in the glioblastoma group the c-erbB-2 protein expression was weak and 17.4% of cases were negative.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP378660.RAmdlkc59U27TjEX9i1-5GS6SQgdrYLRvBkXMCtDlecys130_assertion description "[The strongest c-erbB-2 immunoexpression was observed in low grade astrocytomas (diffuse astrocytomas G2); in the glioblastoma group the c-erbB-2 protein expression was weak and 17.4% of cases were negative.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378660.RAmdlkc59U27TjEX9i1-5GS6SQgdrYLRvBkXMCtDlecys130_provenance.
- NP913759.RAgFrr95whpAEYhd9vhnZ6vMMLbov0iF1_NlggzdpbwyA130_assertion description "[The strongest c-erbB-2 immunoexpression was observed in low grade astrocytomas (diffuse astrocytomas G2); in the glioblastoma group the c-erbB-2 protein expression was weak and 17.4% of cases were negative.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913759.RAgFrr95whpAEYhd9vhnZ6vMMLbov0iF1_NlggzdpbwyA130_provenance.
- NP378941.RAyfNdOgN1Q9cHwIpq5m8DSQnWhM1tLylSkam-QwvcWBg130_assertion description "[The strongest c-erbB-2 immunoexpression was observed in low grade astrocytomas (diffuse astrocytomas G2); in the glioblastoma group the c-erbB-2 protein expression was weak and 17.4% of cases were negative.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378941.RAyfNdOgN1Q9cHwIpq5m8DSQnWhM1tLylSkam-QwvcWBg130_provenance.
- NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_assertion description "[The strongest c-erbB-2 immunoexpression was observed in low grade astrocytomas (diffuse astrocytomas G2); in the glioblastoma group the c-erbB-2 protein expression was weak and 17.4% of cases were negative.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_provenance.